Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Further statement re claim filed by RB

30 Nov 2020 07:00

RNS Number : 8416G
Indivior PLC
30 November 2020
 

Indivior is providing the following statement pursuant to its initial statement dated November 27, 2020, related to a claim filed against it by Reckitt Benckiser Group.

 

Indivior PLC ("Indivior" or "the Company"), as an entitled party, has reviewed the claim Reckitt Benckiser Group ("RB") filed against the Company in the Commercial High Court in London on November 13, 2020. At the present time, the claim has not been served on the Company. Indivior notes reported comments by RB, as published in The Times and Financial Times newspapers on November 27, 2020, that RB "regularly takes certain procedural steps to preserve potential claims."

 

Based on the information available to it, Indivior strongly believes that the claim is without merit and that it has strong grounds for defending against the claim should it be served. If the claim is served, Indivior will fully and vigorously defend itself in any proceedings related to the claim.

 

Indivior will make further announcements as appropriate, including in relation to whether the claim is served.

 

 

For Further Information

Investor Enquiries

 

Jason Thompson

VP, Investor Relations Indivior PLC

+1 804 402 7123

jason.thompson@indivior.com

Media Enquiries

Jonathan Sibun 

Tulchan Communications

US Media Inquiries

 

+44 207 353 4200 

+1 804 594 0836

Indiviormediacontacts@indivior.com

 

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURBLBMTMTITTTM
Date   Source Headline
15th Oct 20247:00 amRNSNotice of Results
15th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 202412:00 pmRNSPreliminary Q3 Results & Updated FY 2024 Guidance
8th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20242:30 pmRNSChair Succession Plan
1st Oct 20247:58 amRNSTotal Voting Rights
1st Oct 20247:00 amRNSTransaction in Own Shares
24th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20247:00 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSHolding(s) in Company
10th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSIndivior Provides Update on AEF0117
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20249:00 amRNSTotal Voting Rights
27th Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:00 amRNSIndivior to Participate in Upcoming Events
14th Aug 20247:36 amRNSHolding(s) in Company
13th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSCompletion of Share Repurchase Program
6th Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20248:24 amRNSTotal Voting Rights
30th Jul 20242:31 pmRNSBlock Listings of Shares
30th Jul 20242:18 pmRNSDirector/PDMR Shareholding
30th Jul 20242:16 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20242:40 pmRNSDirector/PDMR Shareholding
29th Jul 20242:36 pmRNSDirector/PDMR Shareholding
29th Jul 20242:17 pmRNSDirector/PDMR Shareholding
29th Jul 20242:15 pmRNSDirector/PDMR Shareholding
26th Jul 20243:37 pmRNSDirector/PDMR Shareholding
26th Jul 20243:34 pmRNSDirector/PDMR Shareholding
25th Jul 20247:10 amRNSShare Repurchase Program
25th Jul 20247:00 amRNSHalf-year Report
23rd Jul 20247:00 amRNSTransaction in Own Shares
18th Jul 20244:26 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSNotice of Results
12th Jul 20247:00 amRNSHolding(s) in Company
11th Jul 20247:00 amRNSHolding(s) in Company
9th Jul 20247:00 amRNSIndivior Provides Business Update
9th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20243:39 pmRNSHolding(s) in Company
3rd Jul 20241:56 pmRNSHolding(s) in Company
1st Jul 20249:44 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
28th Jun 202410:54 amRNSHolding(s) in Company
28th Jun 202410:32 amRNSHolding(s) in Company
28th Jun 20247:00 amRNSTransaction in Own Shares
27th Jun 20248:06 amRNSTransition to U.S. Primary Listing Complete

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.